Log in to save to my catalogue

Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know

Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a7da1b3e9d10462ca67f2e03ed1145d3

Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know

About this item

Full title

Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know

Publisher

Switzerland: MDPI AG

Journal title

Diagnostics (Basel), 2022-04, Vol.12 (4), p.890

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare type of primary liver malignancy. Among the risk factors, hepatitis B and hepatitis C virus infections, cirrhosis, and male gender are widely reported. The clinical appearance of cHCC-CCA is similar to that of HCC and iCCA and it is usually silent until advanced states, causing a delay...

Alternative Titles

Full title

Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a7da1b3e9d10462ca67f2e03ed1145d3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a7da1b3e9d10462ca67f2e03ed1145d3

Other Identifiers

ISSN

2075-4418

E-ISSN

2075-4418

DOI

10.3390/diagnostics12040890

How to access this item